Supernus Pharmaceuticals (SUPN) null Earnings

17AugConfirmed
Q4 2019
Q1 2020
Q2 2020
Aug 20
0.27
0.4
0.52
0.65

Details

Expected EPS
0.42
Actual EPS
0.65
Surprise EPS
0.23
Surprise Percent
+54.76%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.65 per share for .

0 Comments

Share your thoughts